Related Articles
| Avery Dennison to market wearable sensors |
|
The growing home and remote health care market promises to strip away many of the current costs and wasteful practices associated with medical treatment, while enhancing the quality of life for many people. Proteus has developed a US FDA 510K cleared and European Union CE Mark-certified personal monitoring device for continuous physiologic sensing and monitoring and its new partnership with Avery Dennison aims to reduce cost, enhance wearability and commercialise the technology. It incorporates multiple sensors to monitor important physiological parameters of interest to consumers and clinicians, including heart rate, physical activity and sleep patterns. |
Copyright MCL Global 2013. You may share using our article tools. Please don’t cut articles from ecotextile.com and redistribute by email or post to the web.











